Literature DB >> 25550522

Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome.

Aleisha M Moore1, Mel Prescott1, Christopher J Marshall1, Siew Hoong Yip1, Rebecca E Campbell2.   

Abstract

Polycystic ovarian syndrome (PCOS), the leading cause of female infertility, is associated with an increase in luteinizing hormone (LH) pulse frequency, implicating abnormal steroid hormone feedback to gonadotropin-releasing hormone (GnRH) neurons. This study investigated whether modifications in the synaptically connected neuronal network of GnRH neurons could account for this pathology. The PCOS phenotype was induced in mice following prenatal androgen (PNA) exposure. Serial blood sampling confirmed that PNA elicits increased LH pulse frequency and impaired progesterone negative feedback in adult females, mimicking the neuroendocrine abnormalities of the clinical syndrome. Imaging of GnRH neurons revealed greater dendritic spine density that correlated with increased putative GABAergic but not glutamatergic inputs in PNA mice. Mapping of steroid hormone receptor expression revealed that PNA mice had 59% fewer progesterone receptor-expressing cells in the arcuate nucleus of the hypothalamus (ARN). To address whether increased GABA innervation to GnRH neurons originates in the ARN, a viral-mediated Cre-lox approach was taken to trace the projections of ARN GABA neurons in vivo. Remarkably, projections from ARN GABAergic neurons heavily contacted and even bundled with GnRH neuron dendrites, and the density of fibers apposing GnRH neurons was even greater in PNA mice (56%). Additionally, this ARN GABA population showed significantly less colocalization with progesterone receptor in PNA animals compared with controls. Together, these data describe a robust GABAergic circuit originating in the ARN that is enhanced in a model of PCOS and may underpin the neuroendocrine pathophysiology of the syndrome.

Entities:  

Keywords:  GABA; GnRH; PCOS; luteinizing hormone; progesterone receptor

Mesh:

Substances:

Year:  2014        PMID: 25550522      PMCID: PMC4299257          DOI: 10.1073/pnas.1415038112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Evidence that the arcuate nucleus is an important site of progesterone negative feedback in the ewe.

Authors:  Robert L Goodman; Ida Holaskova; Casey C Nestor; John M Connors; Heather J Billings; Miro Valent; Michael N Lehman; Stanley M Hileman
Journal:  Endocrinology       Date:  2011-06-21       Impact factor: 4.736

2.  In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone.

Authors:  J E Robinson; R A Forsdike; J A Taylor
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

3.  Progesterone-receptive dopaminergic and neuropeptide Y neurons project from the arcuate nucleus to gonadotropin-releasing hormone-rich regions of the ovine preoptic area.

Authors:  Laurence Dufourny; Alain Caraty; Iain J Clarke; Jane E Robinson; Donal C Skinner
Journal:  Neuroendocrinology       Date:  2005-12-05       Impact factor: 4.914

Review 4.  Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.

Authors:  Ricardo Azziz; Catherine Marin; Lalima Hoq; Enkhe Badamgarav; Paul Song
Journal:  J Clin Endocrinol Metab       Date:  2005-06-08       Impact factor: 5.958

5.  Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator.

Authors:  Eileen M Foecking; Marta Szabo; Neena B Schwartz; Jon E Levine
Journal:  Biol Reprod       Date:  2005-03-02       Impact factor: 4.285

6.  Development of a methodology for and assessment of pulsatile luteinizing hormone secretion in juvenile and adult male mice.

Authors:  F J Steyn; Y Wan; J Clarkson; J D Veldhuis; A E Herbison; C Chen
Journal:  Endocrinology       Date:  2013-10-03       Impact factor: 4.736

Review 7.  Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.

Authors:  Christopher R McCartney; Christine A Eagleson; John C Marshall
Journal:  Semin Reprod Med       Date:  2002-11       Impact factor: 1.303

Review 8.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

9.  Transmitter content and afferent connections of estrogen-sensitive progestin receptor-containing neurons in the primate hypothalamus.

Authors:  C Leranth; N J MacLusky; T J Brown; E C Chen; D E Redmond; F Naftolin
Journal:  Neuroendocrinology       Date:  1992-06       Impact factor: 4.914

10.  Hypothalamic and extrahypothalamic mediation of pulsatile discharges of luteinizing hormone in the ovariectomized rat.

Authors:  B D Soper; R F Weick
Journal:  Endocrinology       Date:  1980-01       Impact factor: 4.736

View more
  61 in total

1.  Ovarian Androgens Maintain High GnRH Neuron Firing Rate in Adult Prenatally-Androgenized Female Mice.

Authors:  Eden A Dulka; Laura L Burger; Suzanne M Moenter
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

2.  Dominant Neuropeptide Cotransmission in Kisspeptin-GABA Regulation of GnRH Neuron Firing Driving Ovulation.

Authors:  Richard Piet; Bruna Kalil; Tim McLennan; Robert Porteous; Katja Czieselsky; Allan E Herbison
Journal:  J Neurosci       Date:  2018-06-13       Impact factor: 6.167

3.  Prenatal Testosterone Treatment Leads to Changes in the Morphology of KNDy Neurons, Their Inputs, and Projections to GnRH Cells in Female Sheep.

Authors:  Maria Cernea; Vasantha Padmanabhan; Robert L Goodman; Lique M Coolen; Michael N Lehman
Journal:  Endocrinology       Date:  2015-06-10       Impact factor: 4.736

Review 4.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

Review 5.  Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  J Mol Endocrinol       Date:  2018-10-16       Impact factor: 5.098

6.  Androgens Mediate Sex-Dependent Gonadotropin Expression During Late Prenatal Development in the Mouse.

Authors:  Michael J Kreisman; Christopher I Song; Kathleen Yip; Bryony V Natale; David R Natale; Kellie M Breen
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

7.  Frequent Tail-tip Blood Sampling in Mice for the Assessment of Pulsatile Luteinizing Hormone Secretion.

Authors:  Richard B McCosh; Michael J Kreisman; Kellie M Breen
Journal:  J Vis Exp       Date:  2018-07-04       Impact factor: 1.355

8.  Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring.

Authors:  Min Hu; Jennifer Elise Richard; Manuel Maliqueo; Milana Kokosar; Romina Fornes; Anna Benrick; Thomas Jansson; Claes Ohlsson; Xiaoke Wu; Karolina Patrycja Skibicka; Elisabet Stener-Victorin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

9.  Prepubertal Development of GABAergic Transmission to Gonadotropin-Releasing Hormone (GnRH) Neurons and Postsynaptic Response Are Altered by Prenatal Androgenization.

Authors:  Tova Berg; Marina A Silveira; Suzanne M Moenter
Journal:  J Neurosci       Date:  2018-01-26       Impact factor: 6.167

10.  A GABAergic neural circuit in the ventromedial hypothalamus mediates chronic stress-induced bone loss.

Authors:  Fan Yang; Yunhui Liu; Shanping Chen; Zhongquan Dai; Dazhi Yang; Dashuang Gao; Jie Shao; Yuyao Wang; Ting Wang; Zhijian Zhang; Lu Zhang; William W Lu; Yinghui Li; Liping Wang
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.